Clinical Trial Update: Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography [Phase 3]

View source ↗

Summary

Phase 3 safety and imaging trial of AI-700 in patients with suspected coronary artery disease undergoing coronary angiography has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• AI-700

Snippet

Sponsor: Acusphere | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED